DAFNA Capital Management as of Sept. 30, 2020
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 80 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Stereotaxis Com New (STXS) | 15.9 | $49M | 14M | 3.58 | |
Immunomedics | 7.2 | $22M | 261k | 85.03 | |
Blueprint Medicines (BPMC) | 7.0 | $22M | 233k | 92.70 | |
Fate Therapeutics (FATE) | 5.7 | $18M | 439k | 39.97 | |
Arcturus Therapeutics Hldg I (ARCT) | 3.2 | $9.9M | 230k | 42.90 | |
Sage Therapeutics (SAGE) | 3.1 | $9.7M | 158k | 61.12 | |
Dex (DXCM) | 2.8 | $8.7M | 21k | 412.24 | |
Neurocrine Biosciences (NBIX) | 2.8 | $8.7M | 90k | 96.16 | |
Dicerna Pharmaceuticals | 2.7 | $8.2M | 454k | 17.99 | |
Ishares Tr Nasdaq Biotech Etf (IBB) | 2.5 | $7.6M | 56k | 135.40 | |
Galapagos Nv Spon Adr (GLPG) | 2.0 | $6.3M | 44k | 141.90 | |
Cardiovascular Systems | 1.9 | $6.0M | 151k | 39.35 | |
Proqr Therapeutics N V Shs Euro (PRQR) | 1.9 | $5.9M | 1.2M | 4.79 | |
Arena Pharmaceuticals Com New | 1.8 | $5.7M | 76k | 74.79 | |
Biohaven Pharmaceutical Holding | 1.8 | $5.5M | 85k | 65.01 | |
Applied Genetic Technol Corp C | 1.7 | $5.3M | 1.1M | 4.86 | |
AtriCure (ATRC) | 1.7 | $5.3M | 133k | 39.90 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 1.5 | $4.5M | 29k | 154.32 | |
Ideaya Biosciences (IDYA) | 1.4 | $4.2M | 332k | 12.56 | |
Luminex Corporation | 1.3 | $4.0M | 154k | 26.25 | |
Xenon Pharmaceuticals (XENE) | 1.2 | $3.8M | 347k | 11.07 | |
Constellation Pharmceticls I | 1.2 | $3.7M | 181k | 20.26 | |
Aerie Pharmaceuticals | 1.1 | $3.3M | 284k | 11.77 | |
Radius Health Note 3.000% 9/0 (Principal) | 1.1 | $3.3M | 4.0M | 0.83 | |
Cara Therapeutics (CARA) | 1.0 | $3.1M | 247k | 12.73 | |
Affimed Therapeutics B V | 1.0 | $3.1M | 924k | 3.39 | |
Mersana Therapeutics (MRSN) | 0.9 | $2.8M | 153k | 18.62 | |
89bio (ETNB) | 0.9 | $2.8M | 111k | 25.66 | |
Liquidia Technologies (LQDA) | 0.9 | $2.8M | 575k | 4.92 | |
Otonomy | 0.9 | $2.8M | 689k | 4.05 | |
Biotelemetry | 0.9 | $2.8M | 61k | 45.59 | |
Viking Therapeutics (VKTX) | 0.9 | $2.6M | 451k | 5.82 | |
Kalvista Pharmaceuticals (KALV) | 0.9 | $2.6M | 208k | 12.59 | |
Translate Bio | 0.8 | $2.6M | 191k | 13.61 | |
Accuray Incorporated (ARAY) | 0.8 | $2.6M | 1.1M | 2.40 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $2.6M | 749k | 3.44 | |
Neuronetics (STIM) | 0.8 | $2.4M | 496k | 4.86 | |
Kadmon Hldgs | 0.7 | $2.2M | 564k | 3.92 | |
Spectrum Pharmaceuticals | 0.7 | $2.1M | 515k | 4.08 | |
Mei Pharma Com New | 0.7 | $2.1M | 666k | 3.12 | |
Compugen Ord (CGEN) | 0.6 | $1.9M | 115k | 16.25 | |
Iveric Bio | 0.6 | $1.8M | 323k | 5.64 | |
Bluebird Bio (BLUE) | 0.5 | $1.6M | 30k | 53.94 | |
Syndax Pharmaceuticals (SNDX) | 0.5 | $1.5M | 103k | 14.76 | |
Alector (ALEC) | 0.5 | $1.5M | 140k | 10.54 | |
Harpoon Therapeutics | 0.5 | $1.4M | 85k | 16.99 | |
Johnson & Johnson (JNJ) | 0.5 | $1.4M | 9.4k | 148.83 | |
Alpine Immune Sciences (ALPN) | 0.4 | $1.3M | 148k | 8.79 | |
Arcus Biosciences Incorporated (RCUS) | 0.4 | $1.2M | 72k | 17.14 | |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.4 | $1.2M | 1.5M | 0.80 | |
Larimar Therapeutics (LRMR) | 0.4 | $1.2M | 79k | 15.17 | |
Kura Oncology (KURA) | 0.4 | $1.2M | 39k | 30.65 | |
Sutro Biopharma (STRO) | 0.4 | $1.2M | 119k | 10.05 | |
Phasebio Pharmaceuticals (PHASQ) | 0.4 | $1.1M | 321k | 3.51 | |
Spero Therapeutics (SPRO) | 0.4 | $1.1M | 100k | 11.16 | |
Verona Pharma Sponsored Ads (VRNA) | 0.3 | $1.0M | 162k | 6.24 | |
Apellis Pharmaceuticals (APLS) | 0.3 | $907k | 30k | 30.18 | |
Akebia Therapeutics (AKBA) | 0.3 | $858k | 342k | 2.51 | |
Adicet Bio (ACET) | 0.3 | $803k | 68k | 11.88 | |
Axovant Gene The | 0.3 | $790k | 171k | 4.62 | |
Madrigal Pharmaceuticals (MDGL) | 0.3 | $784k | 6.6k | 118.79 | |
Prevail Therapeutics Ord | 0.2 | $764k | 75k | 10.19 | |
Ardelyx (ARDX) | 0.2 | $759k | 145k | 5.25 | |
Nextcure (NXTC) | 0.2 | $748k | 85k | 8.80 | |
Natus Medical | 0.2 | $735k | 43k | 17.13 | |
Karuna Therapeutics Ord | 0.2 | $714k | 9.2k | 77.35 | |
Masimo Corporation (MASI) | 0.2 | $708k | 3.0k | 236.00 | |
Scpharmaceuticals (SCPH) | 0.2 | $677k | 91k | 7.45 | |
Diamedica Therapeutics Com New (DMAC) | 0.2 | $664k | 157k | 4.24 | |
Chiasma | 0.2 | $659k | 153k | 4.30 | |
Assembly Biosciences | 0.2 | $585k | 36k | 16.45 | |
Gamida Cell SHS (GMDA) | 0.2 | $581k | 140k | 4.15 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $522k | 199k | 2.62 | |
Zymeworks | 0.2 | $463k | 10k | 46.53 | |
Inogen (INGN) | 0.1 | $435k | 15k | 29.00 | |
Radius Health Com New | 0.1 | $249k | 22k | 11.32 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $209k | 22k | 9.47 | |
Aslan Pharmaceuticals Ads | 0.1 | $164k | 86k | 1.91 | |
Lineage Cell Therapeutics In (LCTX) | 0.0 | $89k | 95k | 0.94 | |
Cardiff Oncology (CRDF) | 0.0 | $71k | 5.0k | 14.20 |